UBS Maintains Neutral on Amgen, Raises Price Target to $238
UBS maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $194 to $238.
Morgan Stanley Maintains Equal-Weight on CMS Energy, Raises Price Target to $67
Morgan Stanley maintains CMS Energy (NYSE:CMS) with a Equal-Weight and raises the price target from $64 to $67.
JP Morgan Initiates Coverage On CubeSmart with Neutral Rating, Announces $32 Price Target
JP Morgan analyst Michael Mueller initiates coverage on CubeSmart (NYSE:CUBE) with a Neutral rating and a $32 price…
Wells Fargo Upgrades Bausch Health Companies to Equal-Weight
Wells Fargo analyst Jacob Hughes upgrades Bausch Health Companies (TSX:BHC) from Underweight to Equal-Weight.
Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target
Wells Fargo analyst David Maris downgrades Allergan (NYSE:AGN) from Overweight to Equal-Weight and announces $198 price target.
Credit Suisse Downgrades Yiren Digital to Underperform
Credit Suisse analyst Yirendai Zhong downgrades Yiren Digital (NYSE:YRD) from Neutral to Underperform.
DA Davidson Initiates Coverage On SciPlay with Buy Rating
DA Davidson analyst Franco Granda initiates coverage on SciPlay (NASDAQ:SCPL) with a Buy rating.
Credit Suisse Downgrades Qudian to Neutral
Credit Suisse analyst Charles Zhou downgrades Qudian (NYSE:QD) from Outperform to Neutral.
Stifel Nicolaus Downgrades Lilis Energy to Hold
Stifel Nicolaus analyst Michael Scialla downgrades Lilis Energy (AMEX:LLEX) from Buy to Hold.
Goldman Sachs Upgrades Coca-Cola Femsa to Buy
Goldman Sachs analyst Luca Cipiccia upgrades Coca-Cola Femsa (NYSE:KOF) from Neutral to Buy.